2147 related articles for article (PubMed ID: 23077974)
1. Influence of age and hypertension treatment-time on ambulatory blood pressure in hypertensive patients.
Hermida RC; Ayala DE; Crespo JJ; Mojón A; Chayán L; Fontao MJ; Fernández JR
Chronobiol Int; 2013 Mar; 30(1-2):176-91. PubMed ID: 23077974
[TBL] [Abstract][Full Text] [Related]
2. Influence of circadian time of hypertension treatment on cardiovascular risk: results of the MAPEC study.
Hermida RC; Ayala DE; Mojón A; Fernández JR
Chronobiol Int; 2010 Sep; 27(8):1629-51. PubMed ID: 20854139
[TBL] [Abstract][Full Text] [Related]
3. Relationship between metabolic syndrome, circadian treatment time, and blood pressure non-dipping profile in essential hypertension.
Hermida RC; Chayán L; Ayala DE; Mojón A; Fontao MJ; Fernández JR
Chronobiol Int; 2011 Jul; 28(6):509-19. PubMed ID: 21797779
[TBL] [Abstract][Full Text] [Related]
4. Chronotherapy with valsartan/hydrochlorothiazide combination in essential hypertension: improved sleep-time blood pressure control with bedtime dosing.
Hermida RC; Ayala DE; Mojón A; Fontao MJ; Fernández JR
Chronobiol Int; 2011 Aug; 28(7):601-10. PubMed ID: 21823969
[TBL] [Abstract][Full Text] [Related]
5. Chronotherapy with valsartan/amlodipine fixed combination: improved blood pressure control of essential hypertension with bedtime dosing.
Hermida RC; Ayala DE; Fontao MJ; Mojón A; Fernández JR
Chronobiol Int; 2010 Jul; 27(6):1287-303. PubMed ID: 20653455
[TBL] [Abstract][Full Text] [Related]
6. Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study.
Shimada K; Ogihara T; Saruta T; Kuramoto K;
Clin Ther; 2010 May; 32(5):861-81. PubMed ID: 20685495
[TBL] [Abstract][Full Text] [Related]
7. Circadian pattern of ambulatory blood pressure in untreated hypertensive patients with and without metabolic syndrome.
Ayala DE; Hermida RC; Chayan L; Mojón A; Fontao MJ; Fernández JR
Chronobiol Int; 2009 Aug; 26(6):1189-205. PubMed ID: 19731112
[TBL] [Abstract][Full Text] [Related]
8. Ambulatory blood pressure monitoring in the prediction of cardiovascular events and effects of chronotherapy: rationale and design of the MAPEC study.
Hermida RC
Chronobiol Int; 2007; 24(4):749-75. PubMed ID: 17701685
[TBL] [Abstract][Full Text] [Related]
9. A multicenter, 14-week study of telmisartan and ramipril in patients with mild-to-moderate hypertension using ambulatory blood pressure monitoring.
Lacourcière Y; Neutel JM; Davidai G; Koval S
Am J Hypertens; 2006 Jan; 19(1):104-12. PubMed ID: 16461201
[TBL] [Abstract][Full Text] [Related]
10. Administration time-dependent effects of valsartan on ambulatory blood pressure in elderly hypertensive subjects.
Hermida RC; Calvo C; Ayala DE; Mojón A; Rodríguez M; Chayán L; López JE; Fontao MJ; Soler R; Fernández JR
Chronobiol Int; 2005; 22(4):755-76. PubMed ID: 16147905
[TBL] [Abstract][Full Text] [Related]
11. Administration-time-dependent effects of spirapril on ambulatory blood pressure in uncomplicated essential hypertension.
Hermida RC; Ayala DE; Fontao MJ; Mojón A; Alonso I; Fernández JR
Chronobiol Int; 2010 May; 27(3):560-74. PubMed ID: 20524801
[TBL] [Abstract][Full Text] [Related]
12. Administration-time-dependent effects of olmesartan on the ambulatory blood pressure of essential hypertension patients.
Hermida RC; Ayala DE; Chayan L; Mojon A; Fernandez JR
Chronobiol Int; 2009 Jan; 26(1):61-79. PubMed ID: 19142758
[TBL] [Abstract][Full Text] [Related]
13. Sleep-time blood pressure as a therapeutic target for cardiovascular risk reduction in type 2 diabetes.
Hermida RC; Ayala DE; Mojón A; Fernández JR
Am J Hypertens; 2012 Mar; 25(3):325-34. PubMed ID: 22158066
[TBL] [Abstract][Full Text] [Related]
14. Sex differences in the administration-time-dependent effects of low-dose aspirin on ambulatory blood pressure in hypertensive subjects.
Ayala DE; Hermida RC
Chronobiol Int; 2010 Jan; 27(2):345-62. PubMed ID: 20370474
[TBL] [Abstract][Full Text] [Related]
15. Decreasing sleep-time blood pressure determined by ambulatory monitoring reduces cardiovascular risk.
Hermida RC; Ayala DE; Mojón A; Fernández JR
J Am Coll Cardiol; 2011 Sep; 58(11):1165-73. PubMed ID: 21884956
[TBL] [Abstract][Full Text] [Related]
16. Elevated asleep blood pressure and non-dipper 24h patterning best predict risk for heart failure that can be averted by bedtime hypertension chronotherapy: A review of the published literature.
Hermida RC; Mojón A; Fernández JR; Hermida-Ayala RG; Crespo JJ; Ríos MT; Domínguez-Sardiña M; Otero A; Smolensky MH
Chronobiol Int; 2023 Jan; 40(1):63-82. PubMed ID: 34190016
[TBL] [Abstract][Full Text] [Related]
17. Reduction of morning blood pressure surge after treatment with nifedipine GITS at bedtime, but not upon awakening, in essential hypertension.
Hermida RC; Ayala DE; Mojón A; Alonso I; Fernández JR
Blood Press Monit; 2009 Aug; 14(4):152-9. PubMed ID: 19543080
[TBL] [Abstract][Full Text] [Related]
18. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
[TBL] [Abstract][Full Text] [Related]
19. Comparing different treatment schedules of Zomen (zofenopril).
Bălan H; Popescu E; Angelescu G
Rom J Intern Med; 2011; 49(1):75-84. PubMed ID: 22026256
[TBL] [Abstract][Full Text] [Related]
20. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F
Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
